Trulieve Cannabis (TRLV) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does Trulieve Cannabis (TRLV) do?
Trulieve Cannabis Corp (TRLV) is a U.S.-listed company in Healthcare (Drug Manufacturers - Specialty & Generic). What it does: Cultivates, processes, and dispenses medical and adult-use cannabis products through company-owned dispensaries. Operates a vertically integrated cannabis business with a dominant retail dispensary footprint across Florida. It is worth $1.80B on the market and sold $1.08B over the last year.
- Market cap
- $1.80B
- P/E ratio
- None (reported a loss)
- Annual sales
- $1.08B
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Brief updated
- Nov 19, 2026
Brands and businesses behind TRLV
- Muse: Produces cannabis concentrate extracts and vape cartridges sold through the company dispensary network.
- Modern Flower: Sells mid-tier cannabis flower strains and pre-rolls directly to medical patients and adult-use consumers.
- Sweet Talk: Produces cannabis-infused gummies, chocolates, and other confectionery products for retail dispensary sales.
- Roll One: Offers budget-friendly cannabis flower and pre-rolls designed for cost-conscious retail shoppers.
- Cultivar Collection: Offers craft-grown, hand-trimmed cannabis flower sold at a premium price point in retail stores.
TRLV’s flags, in plain English
Each flag is a number from Trulieve Cannabis’ reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 19, 2026.
Stupid Cash
Can pay this year's bills 5.5 times over. Cash in the bank covers a long stretch of running costs. The company can fund itself without borrowing or selling new shares.
Still Climbing
Sales up 17.8% a year over 5 years. Sales are higher than a year ago. Growth does not guarantee profit, so look at the margins too.
Cheap on Cash Flow
Priced at 10.5 times the cash it generates each year. The share price is low compared with the cash the business actually brings in, and cash is harder to dress up than profit.
Burning Cash
Losing money, profit margin of -41.2%. The business spends more cash than it brings in. It has to cover the gap with cash on hand, new loans or new shares.
2 more green flags and 1 more risk note open with the free trial. Try it free for 7 days.
Questions about TRLV
How big is Trulieve Cannabis?
Trulieve Cannabis’ market cap is $1.80B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $1.08B: what customers paid the company over the last year, before any costs.
What is TRLV’s P/E ratio?
TRLV has no P/E ratio right now. The company reported a loss, so there is no yearly profit to price.
What could go wrong with TRLV?
Federal cannabis prohibition restricts banking access, bars interstate shipments, and imposes punitive income tax treatment under Section 280E. That is one risk on Trulieve Cannabis’ card. Its first risk flag is Burning Cash, explained above. The card holds 1 more risk note for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From Trulieve Cannabis’ own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. TRLV’s filings on SEC.gov. The Margin Monkey is research, not advice.
